Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension

Circulation

Volumn 102, Issue 16, 2000, Pages 1996-2004

  Shimoyama, Masaki ^a   Hayashi, Doubun ^a   Zou, Yunzeng ^a   Takimoto, Eiki ^a   Mizukami, Miho ^a   Monzen, Koshiro ^a   Kudoh, Sumiyo ^a   Hiroi, Yukio ^a   Yazaki, Yoshio ^a   Nagai, Ryozo ^a   Komuro, Issei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Hemodynamics; Hypertension; Hypertrophy

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CYCLOSPORIN A; SODIUM; TACROLIMUS; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE OVERLOAD; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; INHIBITION KINETICS; MALE; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RAT;

EID: 0034680328     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.16.1996     Document Type: Article

References (40)

1. Cardiomyopathy of overload: A major determinant of prognosis in congestive heart failure
2. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study
3. Calcium signalling and cell proliferation
4. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
5. Prevention of cardiac hypertrophy in mice by calcineurin inhibition
6. Control of cardiac gene expression by mechanical stress
7. Load regulation of the properties of adult feline cardiocytes: Growth induction by cellular deformation
8. Cyclosporin attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure
9. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy
10. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats
11. Calcineurin inhibitors and cardiac hypertrophy
12. Calcineurin inhibition and cardiac hypertrophy
13. Pressure-overload induces severe hypertrophy in mice treated with cyclosporin, an inhibitor of calcineurin
14. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion
15. Cardiac hypertrophy and performance of Dahl hypertensive rats on graded salt diets
16. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats
17. Pressure overload induces cardiac hypertrophy in angiotensin II type IA receptor knockout mice
18. Growth, disease, and aging in the rat
19. Use of tibial length to quantify cardiac hypertrophy: Application in the aging rat
20. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure
21. Mechanism of hypertriglyceridemia in Dahl rats
22. Insulin resistance and blood pressure in Dahl rats and in one-kidney, one-clip hypertensive rats
23. Increased expression of interleukin-1β and monocyte chemotactic activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload
24. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocytes hypertrophy
25. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice
26. Transient cardiac expression of constitutive active Gαq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways
27. Effects of age, sex, and breeding status on the rat hearts
28. Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents: Statistical, biological, and clinical significance
29. Relationship of left ventricular mass to fat-free and adipose body mass: The Strong Heart Study
30. Target inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
31. Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene
32. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type
33. Calcineurin is required for skeletal muscle hypertrophy
34. 2+-dependent calcineurin signaling pathway
35. IGF-1 induced skeletal muscle hypertrophy through calcineurin in association with GATA-2 and NF-ATc 1
36. Control of mouse cardiac morphologenesis and myogenesis by transcription factor MEF2C
37. Role of the NF-ATc transcriptional factor in morphogenesis of cardiac valve and septum
38. The transcription factor NF-ATc is essential for cardiac valve formation
39. Calreticulin is essential for cardiac development
40. Pathogenesis of dilated cardiomyopathy: Molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice